I can find no description of haemolytic anaemia in a patient receiving the drug.
I report a case of serious immunohaemolytic anaemia that developed during long-term treatnent with ibuprofen.
Case report
A 69-year-old White woman (weight 72-4 kg) had a 16-year history of moderate intermittent pain and stiffness in the proximal interphalangeal joints, wrists, knees, and ankles. Her complaints varied over the years but the joints were never swollen or deformed, neither rheumatoid factor nor antinuclear antibodies were ever detected, and the erythrocyte sedimentation rate never exceeded 33 mm in the first hour. On several occasions she had been treated for a week to a few months with anti-inflammatory drugs such as phenylbutazone and aspirin without any toxic effects. She had last rereceived treatment a few years before the following episode occurred.
In February 1976 the patient had a moderate relapse of symptoms and for the first time was treated with ibuprofen, 400 mg three times daily. For several months no discomfort or toxic reactions occurred. Then in September, after eight months of continuous treatment, there was an insidious onset of malaise, fatigue, and chills, which became increasingly prominent. A month later she was admitted to the medical ward.
On admission she had no sign of joint deformities but was anaemic and jaundiced, and had a temperature of 38 7°C. Ibuprofen was withdrawn on admission and replaced with prednisone 80 mg daily. The haemolysis slowly diminished. The reticulocytes reached 85% on the fifth day, and serum bilirubin 195 umol/l (11-4 mg/l00 ml) on the 12th day. The haemoglobin began to rise on the 19th day. Twenty-three days after admission the reticulocytes were 2-2%, serum bilirubin was 51-3 jsmol/l (3 0 mg/ 100 ml), and haemoglobin was 11-3 g/dl. That day the patient developed severe pain, and cholelithiasis was diagnosed. Cholecystectomy was performed. In the postoperative period prednisone was discontinued and she received ampicillin, colistin, lincomycin, cephalothin, nitrofurantoin, frusemide, and phenothiazines without any sign of haemolysis.
Comment
Salicylate-like anti-inflammatory drugs such as phenylbutazone, indomethacin, and mefenamic acid have long been known to have serious toxic effects on haemopoiesis. Immunohaemolytic anaemia has also been reported,2 though primarily in patients given mefenamic acid.3 Newer salicylate-like anti-inflammatory drugs, such as the arylalkanoic acids, however, cause few serious toxic reactions. Ibuprofen is one of the most widely used of these drugs, and though it may cause bone marrow depression' it has apparently never before been associated with immunohaemolytic anaemia.
In the present case there was strong evidence of a causal relation between ibuprofen and the immunohaemolytic anaemia. According to the patient and the family doctor she had not received other drugs for several months before admission. Furthermore, she had never had haemolytic anaemia or allergic reactions. The laboratory findings were consistent with immunohaemolytic anaemia, and the cessation of haemolysis when the drug was stopped and the absence of recurrence during and after the steroid treatment confirmed this.
The data do not conclusively indicate the type of haemolysis in this patient; but the chemical similarity of ibuprofen to mefenamic acid, which causes immunohaemolytic anaemia of the methyldopa type,3 the onset of haemolysis after eight months of continuous treatment, the positive direct Coombs test, and the positive antinuclear factor test suggest an autoimmunohaemolytic type.
Though ibuprofen seems to cause few toxic reactions, long-term treatment should probably be given with caution. Whether the direct Coombs test will become positive during long-term treatment, as sometimes occurs with methyldopa, remains to be established, and only further study will show its value in predicting haemolysis. Case history A previously asymptomatic 48-year-old man was admitted to the coronary care unit with severe central chest pain radiating to both arms. Electrocardiography disclosed acute inferior cardiac infarction. On examination he was not shocked and had sinus rhythm of 80 beats/min, blood pressure of 120/80 mm Hg, normal heart sounds, and clear lung fields. Investigations showed: creatinine phosphokinase 611 units; ESR 50 mm in first hout; white cell count 11 x 109/l (11 000/mm3). Three reasons for these events seemed possible: a wide extension of the infarct; a massive pulmonary embolus; or cardiac tamponade. A diagnostic pericardial aspiratio i was performed from the xiphisternal approach, and with the removal of 70 ml of blood the peripheral pulses immediately reappeared, confirming the diagnosis of tamponade. A soft caeter was inserted into the pericardium with a Seldinger wire for continuous aspiration.
